New Alzheimer’s Drug Candidate, A11, Improve Cognition and Memory
Scientists at MIT's Picower Institute developed a promising Alzheimer’s drug candidate, A11. Tested on three mouse strains, A11 showed reduced inflammation, decreased amyloid, and enhanced cognitive performance.